Article thumbnail

Testing bias in clinical databases: methodological considerations

By Karin J Velthove, Hubert GM Leufkens, Patrick C Souverein, René C Schweizer and Wouter W van Solinge
Topics: Methodology
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2885382
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2005). A review of uses of health care utilization databases for epidemiologic research on therapeutics.
  2. (2004). Agreement between GPRD smoking data: a survey of general practitioners and a population-based survey. Pharmacoepidemiol Drug Saf
  3. (2006). Applications of artificial intelligence systems in the analysis of epidemiological data.
  4. (2005). Assessing observational studies of medical treatments. Emerg Themes Epidemiol
  5. (2005). Association of neutrophils and future cardiovascular events in patients with peripheral artery disease. J Vasc Surg
  6. (2006). Asthma: defining of the persistent adult phenotypes. Lancet
  7. (1979). Bias in analytic research.
  8. (1999). Clinical information for research; the use of general practice databases.
  9. (1999). der: Second manifestations of ARTerial disease (SMART) study: rationale and design.
  10. (1999). Difficult/therapyresistant asthma. The need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-resistant asthma. Eur Respir J
  11. (2003). Grobbee DE: Diagnostic research on routine care data: prospects and problems.
  12. (2009). Hematocytometry analysis as discriminative marker for asthma phenotypes. Clin Chem Lab Med
  13. (2007). HT: Cardiovascular and respiratory hospitalizations and mortality among users of tiotropium in Denmark.
  14. International Classification of Diseases, Ninth Revision, Clinical Modification
  15. (1968). Investigation of relation between use of oral contraceptives and thromboembolic disease. BMJ
  16. (2007). Methodologic challenges to studying patient safety and comparative effectiveness. Med Care
  17. (2009). Methodological issues in estimating survival in patients with multiple primary cancers: an application to women with breast cancer as a first tumour. Emerg Themes Epidemiol
  18. (2004). Neutrophil counts, monocyte counts and cardiovascular disease in the elderly. Exp Gerontol
  19. (1989). Neutrophil function in ischemic heart disease. Circulation
  20. (1999). P: Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med
  21. (2007). Solinge WW: Linking laboratory and medication data: new opportunities for pharmacoepidemiological research. Clin Chem Lab Med
  22. (1998). Systemic markers of inflammation in stable bronchiectasis. Eur Respir J
  23. (2008). Validating the effects of drug treatment on blood pressure in the General Practice Research Database. Pharmacoepidemiol Drug Saf
  24. (1999). Vandenbroucke JP: Risk of venous thrombosis with use of current lowdose oral contraceptives is not explained by diagnostic suspicion and referral bias. Arch Intern Med